CLC Number:
[1] Chan C, Goykhman I, Horrow M. Bladder endometriosis: a case report[J]. Ultrasound Q, 2017, 33(1): 98-100. [2] Comiter CV. Endometriosis of the urinary tract[J]. Urol Clin North Am, 2002, 29(3): 625-635. [3] Maccagnano C, Pellucchi F, Rocchini L. Diagnosis and treatment of bladder endometriosis: state of the art[J].Urol Int, 2012, 89(3): 249-258. [4] Saccardi C, Vitagliano A, Litta P. Bladder endometriosis: a summary of current evidence[J]. Minerva Ginecol, 2017, 69(5): 468-476. [5] Villa G, Mabrouk M, Guerrini M. Relationship between site and size of bladder endometriotic nodules and severity of dysuria[J]. J Minim Invasive Gynecol, 2007, 14(5): 628-632. [6] Leone Roberti Maggiore U, Ferrero S, Candiani M. Bladder endometriosis: a systematic review of pathogenesis, diagnosis, treatment, impact on fertility, and risk of malignant transformation[J]. Eur Urol, 2017, 71(5): 790-807. [7] Mallampati GK, Siegelman ES. MR imaging of the bladder[J]. Magn Reson Imaging Clin N Am, 2004, 12(3): 545-555. [8] Litta P, Saccardi C, DAgostino G. Combined transurethral approach with Versapoint(®)and laparoscopic treatment in the management of bladder endometriosis: technique and 12 months follow-up[J]. Surg Endosc, 2012, 26(9): 2446-2450. [9] Ferrero S, Alessandri F, Racca A. Treatment of pain associated with deep endometriosis: alternatives and evidence[J]. Fertil Steril, 2015, 104(4): 771-792. [10] Seracchioli R, Mabrouk M, Montanari G. Conservative laparoscopic man-agement of urinary tract endometriosis: surgical outcome and long-term follow-up[J]. Fertil Steril, 2010, 94(3): 856-861. [11] Chammas MF Jr, Kim FJ, Barbarino A. Asymptomatic rectal and bladder endometriosis: a case for robotic-assisted surgery[J]. Can J Urol, 2008, 15(3): 4097-4100. [12] Vignali M, Bianchi S, Candiani M. Surgical treatment of deep endome-triosis and risk of recurrence[J]. J Minim invasive Gynecol, 2005, 12(6): 508-513. [13] Pérez-Utrilla Pérez M, Aguilera Bazán A, Alonso Dorrego JM. Urinary tract endometriosis: clinical, diagnostic, and therapeutic aspects[J]. Urology, 2009, 73(1): 47-51. |
[1] | ZHANG De-qing, ZHU Yao-feng, MENG Hui, WANG Jun, LI Yan, SHI Ben-kang. Clinical observation on intravesical instillation of sodium hyaluronate for treatment of non-bacterial cystitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 79-82. |
[2] | ZHEN Hongtao1, ZHANG Huaiqiang1, XU Fuyu2, et al. Correlation of TRAIL expression with prognosis of bladder transitional cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(01): 61-63. |
[3] | JIANG Xianzhou, ZHAO Haifeng. Neural regulation of the lower urinary tract [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 19-23. |
[4] | ZHANG Peng. Advances of peripheral nerve stimulation in the treatment of overactive bladder [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 24-28. |
[5] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 118-120. |
[6] | SHI Benkang. Advances in the diagnosis and treatment of overactive bladder [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 1-5. |
[7] | ZHANG Xiulin. Advances in the treatment of overactive bladder by intravesical botulinumtoxin injection [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 12-18. |
[8] | CHONG Tie, CHEN Qi. Clinical application of mirabegron in the treatment of overactive bladder [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 6-11. |
[9] | XU Zhihui, WEI Haibin. Application and progress of sacral neuromodulation in bladder dysfunction [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 29-33. |
|